| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2014-04-11 22:17:03 UTC |
|---|
| Update Date | 2021-09-14 14:58:20 UTC |
|---|
| HMDB ID | HMDB0061656 |
|---|
| Secondary Accession Numbers | - HMDB0094672
- HMDB61656
- HMDB94672
|
|---|
| Metabolite Identification |
|---|
| Common Name | 3-Hydroxytetradecanoic acid |
|---|
| Description | 3-Hydroxytetradecanoic acid (CAS: 1961-72-4) is a long-chain hydroxy fatty acid. In humans fatty acids are predominantly formed in the liver and adipose tissue, and mammary glands during lactation. (R)-3-Hydroxytetradecanoic acid is the most common fatty acid constituent of the lipid A component of bacterial lipopolysaccharides (LPS). 3-Hydroxytetradecanoic acid can be found in feces |
|---|
| Structure | CCCCCCCCCCC[C@H](O)CC(O)=O InChI=1S/C14H28O3/c1-2-3-4-5-6-7-8-9-10-11-13(15)12-14(16)17/h13,15H,2-12H2,1H3,(H,16,17)/t13-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (S)-3-Hydroxymyristic acid | ChEBI | | 3S-Hydroxy-tetradecanoic acid | ChEBI | | C14:0 3(S)-OH | ChEBI | | C14:0 3-OH | ChEBI | | L-beta-Hydroxymyristic acid | ChEBI | | (S)-3-Hydroxymyristate | Generator | | 3S-Hydroxy-tetradecanoate | Generator | | L-b-Hydroxymyristate | Generator | | L-b-Hydroxymyristic acid | Generator | | L-beta-Hydroxymyristate | Generator | | L-Β-hydroxymyristate | Generator | | L-Β-hydroxymyristic acid | Generator | | 3-Hydroxytetradecanoate | Generator | | (S)-3-Hydroxytetradecanoate | HMDB | | (3S)-3-Hydroxytetradecanoate | HMDB | | (3S)-3-Hydroxytetradecanoic acid | HMDB | | (3S)-Hydroxymyristate | HMDB | | (3S)-Hydroxymyristic acid | HMDB | | (S)-beta-Hydroxymyristate | HMDB | | (S)-beta-Hydroxymyristic acid | HMDB | | (S)-Β-hydroxymyristate | HMDB | | (S)-Β-hydroxymyristic acid | HMDB | | (±)-3-hydroxytetradecanoate | HMDB | | (±)-3-hydroxytetradecanoic acid | HMDB | | 3-Hydroxymyristate | HMDB | | 3-Hydroxymyristic acid | HMDB | | FA(14:0(3-OH)) | HMDB | | FA(14:0(3S-OH)) | HMDB | | S-3-Hydroxytetradecanoate | HMDB | | S-3-Hydroxytetradecanoic acid | HMDB | | beta-Hydroxymyristate | HMDB | | beta-Hydroxymyristic acid | HMDB | | beta-Hydroxytetradecanoate | HMDB | | beta-Hydroxytetradecanoic acid | HMDB | | Β-hydroxymyristate | HMDB | | Β-hydroxymyristic acid | HMDB | | Β-hydroxytetradecanoate | HMDB | | Β-hydroxytetradecanoic acid | HMDB | | 3-Hydroxytetradecanoic acid | HMDB |
|
|---|
| Chemical Formula | C14H28O3 |
|---|
| Average Molecular Weight | 244.375 |
|---|
| Monoisotopic Molecular Weight | 244.203844762 |
|---|
| IUPAC Name | (3S)-3-hydroxytetradecanoic acid |
|---|
| Traditional Name | 3-hydroxy-myristic acid |
|---|
| CAS Registry Number | 35683-15-9 |
|---|
| SMILES | CCCCCCCCCCC[C@H](O)CC(O)=O |
|---|
| InChI Identifier | InChI=1S/C14H28O3/c1-2-3-4-5-6-7-8-9-10-11-13(15)12-14(16)17/h13,15H,2-12H2,1H3,(H,16,17)/t13-/m0/s1 |
|---|
| InChI Key | ATRNZOYKSNPPBF-ZDUSSCGKSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Fatty acids and conjugates |
|---|
| Direct Parent | Long-chain fatty acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Long-chain fatty acid
- Hydroxy fatty acid
- Beta-hydroxy acid
- Hydroxy acid
- Secondary alcohol
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Alcohol
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 9.13 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 15.3515 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.7 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2461.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 361.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 177.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 190.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 430.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 690.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 646.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 106.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1396.5 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 484.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1510.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 479.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 391.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 420.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 303.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 33.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 3-Hydroxytetradecanoic acid,1TMS,isomer #1 | CCCCCCCCCCC[C@@H](CC(=O)O)O[Si](C)(C)C | 1982.4 | Semi standard non polar | 33892256 | | 3-Hydroxytetradecanoic acid,1TMS,isomer #2 | CCCCCCCCCCC[C@H](O)CC(=O)O[Si](C)(C)C | 1965.6 | Semi standard non polar | 33892256 | | 3-Hydroxytetradecanoic acid,2TMS,isomer #1 | CCCCCCCCCCC[C@@H](CC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2052.4 | Semi standard non polar | 33892256 | | 3-Hydroxytetradecanoic acid,1TBDMS,isomer #1 | CCCCCCCCCCC[C@@H](CC(=O)O)O[Si](C)(C)C(C)(C)C | 2217.4 | Semi standard non polar | 33892256 | | 3-Hydroxytetradecanoic acid,1TBDMS,isomer #2 | CCCCCCCCCCC[C@H](O)CC(=O)O[Si](C)(C)C(C)(C)C | 2208.6 | Semi standard non polar | 33892256 | | 3-Hydroxytetradecanoic acid,2TBDMS,isomer #1 | CCCCCCCCCCC[C@@H](CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 2514.3 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - 3-Hydroxytetradecanoic acid GC-MS (2 TMS) | splash10-001i-4961000000-5528c5db71884cb54509 | 2019-10-24 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - 3-Hydroxytetradecanoic acid GC-EI-TOF (Non-derivatized) | splash10-0002-1920000000-4232a13b15fd6bcda6d4 | 2019-10-24 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 3-Hydroxytetradecanoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxytetradecanoic acid 10V, Positive-QTOF | splash10-0002-7490000000-e411730b6954cd86436e | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxytetradecanoic acid 20V, Positive-QTOF | splash10-0ab9-9200000000-b7e85c97d8487c52e8cc | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxytetradecanoic acid 40V, Positive-QTOF | splash10-0a4l-9000000000-0525dd3ff78d95a6db8e | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxytetradecanoic acid 10V, Negative-QTOF | splash10-052f-7090000000-d25b3956d871bbed563c | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxytetradecanoic acid 20V, Negative-QTOF | splash10-0a4i-9000000000-a79b5cb90536466a51ca | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-Hydroxytetradecanoic acid 40V, Negative-QTOF | splash10-0006-9000000000-20ac637addcc98814c6d | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|
| Disease References | | Colorectal cancer |
|---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
|
|
|---|